NEWS
Fertility Still Possible for Many Male Cancer Survivors, Study Finds
In the retrospective study, researchers from New York-Presbyterian Hospital/Weill Cornell Medical Center showed that nearly 2 decades after cancer treatment, healthy sperm could be retrieved from the testicles of more than one-third of male cancer survivors who had a condition in which no viable sperm was detectable in their semen. Read more > > |
U.S. Cancer Survivors Increase to Nearly 12 Million
Breast, prostate, and colorectal cancers were the most common types among survivorsThyroid Cancer Risk Persists in People Exposed to I-131 Radiation as Children
Follow up from the Chernobyl nuclear disaster shows risk remains 2 decades after the accidentIncidence Rate of Second Cancer in the Opposite Breast Has Declined in U.S.
The trend corresponds to widespread increase in use of tamoxifenEribulin Improves Survival of Women with Metastatic Breast Cancer
Results from the trial were the basis for FDA approvalExperimental Strategy May Overcome Resistance to Breast Cancer Drug
In preclinical experiments, the strategy made cells more responsive to trastuzumab
COMMENTARY
Devastation and Hope: An NCI Scientist's First-Hand Account of Japan's Resilience
by Dr. James L. Gulley As the horrifying events and aftermath of the Japanese earthquake and tsunami continue to unfold on our television and computer screens, it’s difficult to imagine how any nation could recover from such calamities. But, based on what I personally witnessed, I have great hope for Japan’s future. Read more > > |
A MESSAGE TO READERS
Coverage of AACR Annual Meeting
The American Association for Cancer Research 102nd Annual Meeting will take place April 2–6 in Orlando, FL. Click on the tile to learn more about NCI-sponsored sessions and activities at the NCI exhibit booth. Look for highlights from the meeting in the April 5 issue of the NCI Cancer Bulletin.
IN DEPTH
Colorectal Cancer Test Targets Cancer Stem Cells in Blood
Circulating cancer stem cells may identify patients with aggressive diseaseMiniaturized Device Puts Nanotechnology to Work in Diagnosing Cancer
Nuclear magnetic resonance device could augment conventional diagnostic methodsFeatured Clinical Trial: Novel Combination Chemotherapy for Localized Ewing Sarcoma
Will additional chemotherapy improve survival of children and young adults with Ewing sarcoma?
UPDATES
FDA Update
- Menthol Cigarettes Adversely Affect Public Health, FDA Advisory Committee Finds
Notes
- National Cancer Clinical Trials Cooperative Groups Announce Mergers
- Research Symposium on Radiation and Cancer Honors Dr. Elaine Ron
- Funding to Support Collaborations between U.S. and Chinese Scientists
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.



